Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tianjin Chest Hospital
With
LinkDoc Technology (Beijing) Co. Ltd.
A multi-centre real-world non-interventional observational study to retrospectively collect the study data on patient demographic/tumor biological characteristics and clinical treatments to compare patient survivals in the N2 patients with non-small cell lung cancer in the subgroups of lymph skip metastases and non-skip metastases.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with surgeries from 2014 to 2017;
Pathologically diagnosed patients with non-small cell lung cancer;
Age \> 18 years old;
Patients with chest surgeries before hospitalization;
Patients with N2 lymph nodes (+) after surgeries who received lymphadenectomy (Group 10 and 11 lymph nodes);
You may not be if
\- Patients with radiotherapies, chemotherapies and biological therapies for tumors
Clareo Health | A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
